We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Gas Analyzer Focuses on Safety at POC

By LabMedica International staff writers
Posted on 29 Dec 2010
Print article
Image: The Roche cobas b 123 blood gas analyzer (photo courtesy Roche).
Image: The Roche cobas b 123 blood gas analyzer (photo courtesy Roche).
A new blood gas analyzer was designed specifically to be used at the point of care (POC).

The compact cobas b 123 is ideal for use in critical care units, emergency rooms, and other POC settings. Easy to use and virtually maintenance free, it incorporates a number of important infection control features and ensures minimal downtime with reliable, clot-free operation.

The only manual maintenance step required for the new instrument is the replacement of consumables.
Its highly durable electronics and mechanics make it robust and reliable, ensuring minimal downtime and saving time required at the machine. Clot-free operation ensures that there is no unnecessary disruption to routine or waste of reagents.

The instrument requires minimal training of staff. With touch screen operation, the system guides the user through operational processes systematically. The press of a single button is all that is required to initiate sampling and measurement.

The new analyzer has many infection control and safety features. There are no exposed needles and the protected sample input area remains closed during operation and between samples. Infection control is further enhanced by the collection of waste in a sealed pack within the closed system. Password authorization ensures safe and appropriate use by locking the instrument to unauthorized/untrained users.

The cobas b 123 includes all important critical care parameters including blood gases, hematocrit, bilirubin, electrolytes, glucose, and lactate. To make interpretation of results as easy as possible, the large, color display screen presents unambiguous readings, with measurements that fall outside predefined acceptable limits highlighted clearly.

The need for scanning barcodes and swapping the consumables across instruments is made redundant by Smart chips on the consumables (sensors, fluid packs, and quality control--QC packs). Because sensors are separate from the fluid pack, the latter can be stored at room temperature. Inventory status is displayed clearly on the screen and step-by-step prompts guide the user through the changing of consumables.

The footprint of the analyzer for environments where there is limited space is reduced by the front loading feature. Data can be transferred across instruments using a simple media card.

The new cobas b 123 POC system is the latest blood gas analyzer from Roche (Basel, Switzerland). It is due to be launched in the UK and Ireland in February 2011.

Dr. Thomas Vering, head of the Roche global sensor program, commented, "Consolidation of important critical care tests on one system allows medical professionals in critical care and emergency settings to obtain rapid answers to a broad range of medical questions. The cobas b 123 is flexible and configurable to accommodate individual needs and with its intuitive operation and excellent connectivity options, it is ideal for use at the point of care.”

Related Links:
Roche


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Biological Indicator Vials
BI-O.K.

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.